What abrdn World Healthcare Fund's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 0 |
| Total trades | 0 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 796 |
| Disposed | 0 | 0 |
| Net activity | +0 | +796 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mahai Chris LaVictoire | Director | Jul 16 | Open-market buy · P | +796 | $13.20 | +$10.5K | 796 |
| Maher Bill | Director | Aug 14 | Open-market buy · P | +1,000 | $13.03 | +$13K | 1,000 |
| DiMartino Rose | Director | Jul 16 | Open-market buy · P | +1,000 | $13.31 | +$13.3K | 1,000 |
| Goetz Kathleen | Director | Apr 09 | Open-market buy · P | +200 | $12.53 | +$2.51K | 1,017 |
| Reit Todd | Director | Jan 02 | Open-market buy · P | +1,000 | $11.94 | +$11.9K | 1,000 |
| Goetz Kathleen | Director | Mar 23 | Open-market buy · P | +103 | $14.52 | +$1.5K | 817 |
| Goetz Kathleen | Director | Jan 26 | Open-market buy · P | +714 | $14.60 | +$10.4K | 714 |
| Kent Thomas M | Director | Apr 06 | In/At-money Exercise · X | +600 | $14.26 | +$8.56K | 2,400 |
| Omstead Daniel R | President | Apr 06 | In/At-money Exercise · X | +6,442 | $14.26 | +$91.9K | 30,768 |
| Reardon William S | Director | Apr 06 | In/At-money Exercise · X | +486 | $14.26 | +$6.93K | 1,946 |
| Stebbins Lucinda H | Director | Apr 06 | In/At-money Exercise · X | +250 | $14.26 | +$3.57K | 1,000 |
| Bailey Jeffrey Allen | Director | Apr 06 | In/At-money Exercise · X | +245 | $14.26 | +$3.49K | 980 |
| Reardon William S | Director | Feb 25 | Open-market buy · P | +1,460 | $17.14 | +$25K | 1,460 |
| Stebbins Lucinda H | Director | Feb 19 | Open-market buy · P | +750 | $16.80 | +$12.6K | 750 |
| Bailey Jeffrey Allen | Director | Sep 23 | Open-market buy · P | +710 | $14.18 | +$10.1K | 710 |
| Omstead Daniel R | President | Mar 17 | Open-market buy · P | +9,926 | $10.77 | +$107K | 24,326 |
| Omstead Daniel R | President | Dec 26 | Open-market buy · P | +9,400 | $11.11 | +$104K | 14,400 |
| Kent Thomas M | Director | Jan 25 | Open-market buy · P | +1,800 | $14.52 | +$26.1K | 1,800 |
| Gasperoni Timothy L | Insider | Jan 06 | Open-market buy · P | +1,592 | $15.72 | +$25K | 1,592 |
| Bonney Michael W | Director | Aug 17 | Open-market buy · P | +10,917 | $18.35 | +$200K | 10,917 |
Loading...